ADUS:NSD-Addus HomeCare Corporation (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 106.06

Change

-0.67 (-0.63)%

Market Cap

USD 1.71B

Volume

0.04M

Avg Analyst Target

USD 113.00 (+6.54%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ADUS Stock Forecast & Price:
Based on the Addus HomeCare Corporation stock forecasts from 6 analysts, the average analyst target price for Addus HomeCare Corporation is USD 113.00 over the next 12 months. Addus HomeCare Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Addus HomeCare Corporation is Slightly Bullish , which is based on 7 positive signals and 4 negative signals. At the last closing, Addus HomeCare Corporation’s stock price was USD 106.06. Addus HomeCare Corporation’s stock price has changed by -3.83% over the past week, -3.40% over the past month and +15.05% over the last year.

About Addus HomeCare Corporation (ADUS:NSD)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-12-07 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

-2.77 (-3.27%)

USD7.45B 26.69 16.67
OPCH Option Care Health Inc

-0.30 (-1.00%)

USD5.50B 29.34 21.16
ENSG The Ensign Group Inc

+0.57 (+0.62%)

USD5.23B 25.14 18.43
LHCG LHC Group

+2.54 (+1.56%)

USD5.02B 79.28 30.52
SGRY Surgery Partners Inc

+0.32 (+1.21%)

USD3.31B 63.00 14.11
AMED Amedisys Inc

-0.18 (-0.21%)

USD2.81B 23.40 13.59
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
LFST Lifestance Health Group Inc

+0.06 (+1.07%)

USD2.12B N/A -10.62
CCRN Cross Country Healthcare Inc

-1.18 (-3.52%)

USD1.37B 6.11 4.77
AMEH Apollo Medical Holdings Inc

-0.41 (-1.38%)

USD1.35B 21.00 16.65

ETFs Containing ADUS

Symbol Name Weight Mer Price(Change) Market Cap
SBM ProShares Short Basic Mat.. 7.23 % 0.95 %

N/A

USD1.85M
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

N/A

USD4.76M
ABEQ Absolute Core Strategy ET.. 5.53 % 0.85 %

+0.02 (+0.07%)

USD0.08B
ZPDM:XETRA SPDR S&P U.S. Materials S.. 4.41 % 0.15 %

-0.02 (-0.05%)

USD0.07B
ZPDM:F SPDR S&P U.S. Materials S.. 4.41 % 0.15 %

-0.30 (-0.80%)

USD0.07B
JHMA John Hancock Multifactor .. 4.37 % 0.40 %

N/A

USD0.01B
2B7B:XETRA iShares S&P 500 Materials.. 4.34 % 0.15 %

-0.01 (-0.09%)

USD0.12B
RTM Invesco S&P 500® Equal W.. 4.30 % 0.40 %

-0.63 (-0.38%)

USD0.34B
XLB Materials Select Sector S.. 3.89 % 0.10 %

-0.18 (-0.22%)

USD5.47B
IMSU:LSE iShares S&P 500 Materials.. 3.89 % 0.15 %

+2.75 (+0.39%)

USD0.12B
IUMS:LSE iShares S&P 500 Materials.. 3.89 % 0.15 %

N/A

USD0.14B
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.70 %

-59.50 (-0.85%)

USD0.28B
IDAT Ishares Trust - Cloud Dat.. 3.46 % 0.47 %

-0.15 (-0.67%)

USD7.00M
UYM ProShares Ultra Basic Mat.. 3.35 % 0.95 %

-0.17 (-0.73%)

USD0.04B
FMAT Fidelity® MSCI Materials.. 2.95 % 0.08 %

-0.10 (-0.22%)

USD0.45B
GENG:LSE UBS (Irl) ETF plc - Globa.. 1.24 % 0.30 %

-5.80 (-0.34%)

USD0.08B
GENE:LSE UBS (Irl) ETF Public Limi.. 1.24 % 0.30 %

-1.70 (-0.13%)

USD0.45B
SZNE Pacer CFRA-Stovall Equal .. 1.09 % 0.60 %

-0.11 (-0.32%)

USD0.07B
FTA First Trust Large Cap Val.. 1.06 % 0.59 %

-0.15 (-0.22%)

USD1.20B
GEND:LSE Lyxor Global Gender Equal.. 0.82 % 0.20 %

-0.01 (-0.08%)

USD0.06B
ELLE:LSE Lyxor Index Fund - Lyxor .. 0.81 % 0.20 %

-0.08 (-0.60%)

USD0.05B
VMO:CA Vanguard Global Momentum .. 0.68 % 0.37 %

+0.03 (+0.07%)

USD0.06B
VVAL:LSE Vanguard Global Value Fac.. 0.54 % 0.00 %

N/A

USD0.24B
SCHI Schwab 5-10 Year Corporat.. 0.13 % 0.03 %

+0.37 (+0.84%)

USD0.43B
VCIT Vanguard Intermediate-Ter.. 0.10 % 0.04 %

+0.60 (+0.76%)

USD38.84B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.03 %

+0.20 (+0.41%)

USD0.35B
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.04 %

+0.27 (+0.36%)

USD45.14B
VCLT Vanguard Long-Term Corpor.. 0.07 % 0.04 %

+1.20 (+1.50%)

USD4.93B
BIV Vanguard Intermediate-Ter.. 0.05 % 0.04 %

+0.57 (+0.75%)

USD31.36B
BLV Vanguard Long-Term Bond I.. 0.04 % 0.04 %

+1.33 (+1.73%)

USD6.88B
BSV Vanguard Short-Term Bond .. 0.02 % 0.04 %

+0.26 (+0.34%)

USD65.21B
SCHZ Schwab U.S. Aggregate Bon.. 0.01 % 0.03 %

+0.43 (+0.92%)

USD6.85B
VAW Vanguard Materials Index .. 0.00 % 0.10 %

-0.48 (-0.27%)

USD3.65B
DGT SPDR® Global Dow ETF 0.00 % 0.50 %

-0.03 (-0.03%)

USD0.09B
FAB First Trust Multi Cap Val.. 0.00 % 0.69 %

-0.10 (-0.15%)

USD0.19B
UTRN Vesper U.S. Large Cap Sho.. 0.00 % 0.75 %

+0.16 (+0.63%)

USD0.07B
SXLB:LSE SPDR S&P U.S. Materials S.. 0.00 % 0.15 %

-0.06 (-0.16%)

USD0.07B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.42% 85% B 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.42% 85% B 92% A-
Trailing 12 Months  
Capital Gain 13.76% 85% B 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.76% 85% B 92% A-
Trailing 5 Years  
Capital Gain 220.42% 85% B 92% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 220.42% 85% B 92% A-
Average Annual (5 Year Horizon)  
Capital Gain 17.51% 60% D- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.51% 60% D- 80% B-
Risk Return Profile  
Volatility (Standard Deviation) 28.76% 72% C- 57% F
Risk Adjusted Return 60.90% 80% B- 91% A-
Market Capitalization 1.71B 76% C 82% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 38.99 47% F 26% F
Price/Book Ratio 2.81 45% F 31% F
Price / Cash Flow Ratio 43.27 10% F 6% F
EV/EBITDA 23.35 17% F 9% F
Management Effectiveness  
Return on Equity 7.56% 79% C+ 67% D+
Return on Invested Capital 6.91% 57% F 70% C-
Return on Assets 5.09% 79% C+ 85% B
Debt to Equity Ratio 38.46% 60% D- 44% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 4.28 64% D 34% F
Short Percent 4.26% 77% C+ 34% F
Beta 0.79 70% C- 68% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.